5 Gyeonggi Bio Companies Join Boston Investment Program

The local Boston schedule for the ‘2025 US Bio Investment Attraction Capacity Building Program,’ hosted and organized by Gyeonggi Province and Gyeonggi Economic & Science Accelerator (GESA), successfully commenced on September 15 (local time) and proceeded for two days. Five participating companies, including Deepson Bio, Radahaim, Raonmedy, Billix, and Exosystems, had the opportunity to deeply explore strategies for entering the US market and attracting investment. On the first day, participating companies at CIC Cambridge received practical information from officials of the Korea Technology and Information Promotion Agency for SMEs and the U.S. branch of the Korea Health Industry Development Institute regarding R&D government funding and policy support measures. In the afternoon, they shared vivid local experiences and strengthened their networking through a meeting with domestic companies already established in the U.S. market. In the evening, they broadened the scope of their exchanges with a dinner with officials from the Korean-American Society of Biotech and Pharmaceuticals (KASBP). On the morning of the second day, an intensive pitching session was held in preparation for the upcoming ‘RESI Boston 2025’ Innovator’s Pitch Challenge (IPC). The local Boston judging panel provided sharp evaluations from an investor's perspective and specific feedback, elevating the companies' pitching capabilities to the next level. In the afternoon, through a seminar with local experts from EisnerAmper, Eva Garland Consulting, LabCentral, and others, they acquired essential knowledge for entering the US market, including tax and financial management, R&D strategy development, and how to utilize bio clusters. Additionally, one-on-one consultations with CEO Woojung Hoon of BW Biomed were conducted, offering customized advice. Son Mi-kyung, CEO of Genaxis, who is in charge of operating the program, stated, "During the initial two days, companies went through the process of materializing their global market entry strategies across various aspects, including policy, investment, and networking." She added, "We expect to create tangible investment outcomes and cooperation opportunities through the upcoming RESI BOSTON." Gyeonggi Province's bio companies are solidifying a strong foundation to leap onto the global stage through this program.